Clearwater Capital Advisors, LLC Pfizer Inc Transaction History

Clearwater Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $46 - $55	-1 Reduced 0.02%	4,269 $224,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $176,436 - $261,537	4,270 New	4,270 $252,000
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $213,633 - $239,861	-5,777 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $9,562 - $10,506	255 Added 4.62%	5,777 $245,000
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $8,886 - $10,131	231 Added 4.37%	5,522 $241,000
Q3 2018 Oct 17, 2018	BUY	$34.47 - $41.81 $182,380 - $221,216	5,291 New	5,291 $233,000
Q2 2018 Aug 16, 2018	SELL	$32.98 - $35.16 $144,914 - $154,493	-4,394 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $140,212 - $162,665	4,394 New	4,394 $156,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.